Vantage Investment Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | $25K | Hold |
3,605
| – | – | 0.01% | 389 |
|
|
2018
Q2 | $24K | Hold |
3,605
| – | – | 0.01% | 383 |
|
|
2018
Q1 | $23K | Hold |
3,605
| – | – | 0.01% | 401 |
|
|
2017
Q4 | $16K | Hold |
3,605
| – | – | ﹤0.01% | 486 |
|
|
2017
Q3 | $22K | Hold |
3,605
| – | – | 0.01% | 421 |
|
|
2017
Q2 | $33K | Hold |
3,605
| – | – | 0.01% | 335 |
|
|
2017
Q1 | $33K | Hold |
3,605
| – | – | 0.01% | 318 |
|
|
2016
Q4 | $30K | Hold |
3,605
| – | – | 0.01% | 336 |
|
|
2016
Q3 | $25K | Hold |
3,605
| – | – | 0.01% | 355 |
|
|
2016
Q2 | $18K | Buy |
3,605
+3,505
| +3,505% | +$17.5K | 0.01% | 436 |
|
|
2016
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 771 |
|
|
2015
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 743 |
|
|
2015
Q3 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 747 |
|